{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["angiogenesis", "head and neck cancer", "integrative therapy", "metastasis", "oral mucositis", "traditional herbal medicine", "tumor growth", "xerostomia"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32942674", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "24"}, "DateRevised": {"Year": "2021", "Month": "06", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "15"}], "Language": ["eng"], "ELocationID": ["1321", "10.3390/biom10091321"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "10", "Issue": "9", "PubDate": {"Year": "2020", "Month": "Sep", "Day": "15"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Traditional Herbal Medicine Mediated Regulations during Head and Neck Carcinogenesis.", "Abstract": {"AbstractText": ["Head and neck squamous cell carcinoma (HNSCC) is one of the most prevalent neoplasms worldwide. It is well recognized that environmental challenges such as smoking, viral infection and alcohol consumption are key factors underlying HNSCC pathogenesis. Other than major clinical interventions (e.g., surgical resection, chemical and radiotherapy) that have been routinely practiced over years, adjuvant anticancer agents from Traditional Herbal Medicine (THM) are proposed, either alone or together with conventional therapies, to be experimentally effective for improving treatment efficacy in different cancers including HNSCCs. At a cellular and molecular basis, THM extracts could modulate different malignant indices via distinct signaling pathways and provide better control in HNSCC malignancy and its clinical complications such as radiotherapy-induced xerostomia/oral mucositis. In this article, we aim to systemically review the impacts of THM in regulating HNSCC tumorous identities and its potential perspective for clinical use."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan."}], "LastName": "Lan", "ForeName": "Xiang-Yun", "Initials": "XY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dentistry, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan."}], "LastName": "Chung", "ForeName": "Tzu-Ting", "Initials": "TT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Technology and Informatics (HTI), The Hong Kong Polytechnic University (PolyU), Hung Hom, Kowloon, Hong Kong, SAR, China."}], "LastName": "Huang", "ForeName": "Chien-Ling", "Initials": "CL"}, {"Identifier": ["0000-0002-0340-7557"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei 11221, Taiwan."}, {"Identifier": [], "Affiliation": "Cancer Progression Research Center, National Yang-Ming University, Taipei 11221, Taiwan."}], "LastName": "Lee", "ForeName": "Yi-Jang", "Initials": "YJ"}, {"Identifier": ["0000-0003-0481-4215"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Dentistry, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan."}, {"Identifier": [], "Affiliation": "Cancer Progression Research Center, National Yang-Ming University, Taipei 11221, Taiwan."}], "LastName": "Li", "ForeName": "Wan-Chun", "Initials": "WC"}], "GrantList": [{"GrantID": "109-2628-B-010-008-", "Agency": "Ministry of Science and Technology, Taiwan", "Country": "International"}, {"GrantID": "106-2314-B-010-005-MY3", "Agency": "Ministry of Science and Technology, Taiwan", "Country": "International"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Neoplasm Proteins"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug therapy", "genetics", "metabolism", "pathology"], "DescriptorName": "Carcinoma, Squamous Cell"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Gamma Rays"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": ["drug therapy", "genetics", "metabolism", "pathology"], "DescriptorName": "Head and Neck Neoplasms"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lymphatic Metastasis"}, {"QualifierName": ["methods"], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "Neoplasm Proteins"}, {"QualifierName": ["genetics", "metabolism", "pathology", "prevention & control"], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["etiology", "genetics", "metabolism", "pathology"], "DescriptorName": "Stomatitis"}, {"QualifierName": [], "DescriptorName": "Taiwan"}, {"QualifierName": ["etiology", "genetics", "metabolism", "pathology"], "DescriptorName": "Xerostomia"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cohen N., Fedewa S., Chen A.Y. Epidemiology and Demographics of the Head and Neck Cancer Population. Oral. Maxillofac. Surg. Clin. N. Am. 2018;30:381\u2013395. doi: 10.1016/j.coms.2018.06.001.", "ArticleIdList": ["10.1016/j.coms.2018.06.001", "30078696"]}, {"Citation": "Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat. Rev. Cancer. 2011;11:9\u201322. doi: 10.1038/nrc2982.", "ArticleIdList": ["10.1038/nrc2982", "21160525"]}, {"Citation": "Chen T.Y., Hsieh Y.T., Huang J.M., Liu C.J., Chuang L.T., Huang P.C., Kuo T.Y., Chia H.Y., Chou C.Y., Chang C.W., et al. Determination of Pyruvate Metabolic Fates Modulates Head and Neck Tumorigenesis. Neoplasia. 2019;21:641\u2013652. doi: 10.1016/j.neo.2019.04.007.", "ArticleIdList": ["10.1016/j.neo.2019.04.007", "PMC6522776", "31100640"]}, {"Citation": "Meurman J.H. Infectious and dietary risk factors of oral cancer. Oral. Oncol. 2010;46:411\u2013413. doi: 10.1016/j.oraloncology.2010.03.003.", "ArticleIdList": ["10.1016/j.oraloncology.2010.03.003", "20381409"]}, {"Citation": "Al-Sarraf M. Treatment of locally advanced head and neck cancer: Historical and critical review. Cancer Control. 2002;9:387\u2013399. doi: 10.1177/107327480200900504.", "ArticleIdList": ["10.1177/107327480200900504", "12410178"]}, {"Citation": "Matovina C., Birkeland A.C., Zick S., Shuman A.G. Integrative Medicine in Head and Neck Cancer. Otolaryngol. Head Neck Surg. 2017;156:228\u2013237. doi: 10.1177/0194599816671885.", "ArticleIdList": ["10.1177/0194599816671885", "PMC5619701", "27729559"]}, {"Citation": "Miller M.C., Pribitkin E.A., Difabio T., Keane W.M. Prevalence of complementary and alternative medicine use among a population of head and neck cancer patients: A survey-based study. Ear Nose Throat J. 2010;89:E23\u2013E27. doi: 10.1177/014556131008901005.", "ArticleIdList": ["10.1177/014556131008901005", "20981649"]}, {"Citation": "Warrick P.D., Irish J.C., Morningstar M., Gilbert R., Brown D., Gullane P. Use of alternative medicine among patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 1999;125:573\u2013579. doi: 10.1001/archotol.125.5.573.", "ArticleIdList": ["10.1001/archotol.125.5.573", "10326817"]}, {"Citation": "Luo H., Vong C.T., Chen H., Gao Y., Lyu P., Qiu L., Zhao M., Liu Q., Cheng Z., Zou J., et al. Naturally occurring anti-cancer compounds: Shining from Chinese herbal medicine. Chin. Med. 2019;14:48. doi: 10.1186/s13020-019-0270-9.", "ArticleIdList": ["10.1186/s13020-019-0270-9", "PMC6836491", "31719837"]}, {"Citation": "Wang S., Wu X., Tan M., Gong J., Tan W., Bian B., Chen M., Wang Y. Fighting fire with fire: Poisonous Chinese herbal medicine for cancer therapy. J. Ethnopharmacol. 2012;140:33\u201345. doi: 10.1016/j.jep.2011.12.041.", "ArticleIdList": ["10.1016/j.jep.2011.12.041", "22265747"]}, {"Citation": "Zhong Z., Zhang Q., Tao H., Sang W., Cui L., Qiang W., Cheang W.S., Hu Y., Yu H., Wang Y. Anti-inflammatory activities of Sigesbeckia glabrescens Makino: Combined in vitro and in silico investigations. Chin. Med. 2019;14:35. doi: 10.1186/s13020-019-0260-y.", "ArticleIdList": ["10.1186/s13020-019-0260-y", "PMC6757439", "31572487"]}, {"Citation": "Sivanantham B., Sethuraman S., Krishnan U.M. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways. ACS Comb. Sci. 2016;18:22\u201335. doi: 10.1021/acscombsci.5b00043.", "ArticleIdList": ["10.1021/acscombsci.5b00043", "26505786"]}, {"Citation": "Jiang J.H., Pi J., Jin H., Cai J.Y. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways. J. Cell Biochem. 2019;120:3736\u20133746. doi: 10.1002/jcb.27654.", "ArticleIdList": ["10.1002/jcb.27654", "30229997"]}, {"Citation": "Zhou P., Zhang R., Wang Y., Xu D., Zhang L., Qin J., Su G., Feng Y., Chen H., You S., et al. Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals. Oncotarget. 2017;8:111144\u2013111160. doi: 10.18632/oncotarget.22676.", "ArticleIdList": ["10.18632/oncotarget.22676", "PMC5762312", "29340044"]}, {"Citation": "Johnson D.G., Walker C.L. Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 1999;39:295\u2013312. doi: 10.1146/annurev.pharmtox.39.1.295.", "ArticleIdList": ["10.1146/annurev.pharmtox.39.1.295", "10331086"]}, {"Citation": "Hashimoto T., Kikkawa U., Kamada S. Contribution of caspase(s) to the cell cycle regulation at mitotic phase. PLoS ONE. 2011;6:e18449. doi: 10.1371/journal.pone.0018449.", "ArticleIdList": ["10.1371/journal.pone.0018449", "PMC3068168", "21479177"]}, {"Citation": "Yanchun M., Yi W., Lu W., Yu Q., Jian Y., Pengzhou K., Ting Y., Hongyi L., Fang W., Xiaolong C., et al. Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway. Eur. J. Pharmacol. 2019;851:43\u201351. doi: 10.1016/j.ejphar.2019.02.030.", "ArticleIdList": ["10.1016/j.ejphar.2019.02.030", "30779917"]}, {"Citation": "Hung C.-M., Chang C.-C., Lin C.-W., Ko S.-Y., Hsu Y.-C. Cucurbitacin E as inducer of cell death and apoptosis in human oral squamous cell carcinoma cell line SAS. Int. J. Mol. Sci. 2013;14:17147\u201317156. doi: 10.3390/ijms140817147.", "ArticleIdList": ["10.3390/ijms140817147", "PMC3759956", "23965977"]}, {"Citation": "Liu L., Zuo L.F., Zuo J., Wang J. Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo. Mol. Med. Rep. 2015;12:1465\u20131472. doi: 10.3892/mmr.2015.3517.", "ArticleIdList": ["10.3892/mmr.2015.3517", "25816175"]}, {"Citation": "Zhang Z., Lin R., Liu Z., Yan T., Xia Y., Zhao L., Lin F., Zhang X., Li C., Wang Y. Curcumin analog, WZ37, promotes G2/M arrest and apoptosis of HNSCC cells through Akt/mTOR inhibition. Toxicol. In Vitr. 2020;65:104754. doi: 10.1016/j.tiv.2019.104754.", "ArticleIdList": ["10.1016/j.tiv.2019.104754", "31863822"]}, {"Citation": "Harada T., Harada K., Ueyama Y. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma. Int. J. Oncol. 2012;41:565\u2013572. doi: 10.3892/ijo.2012.1501.", "ArticleIdList": ["10.3892/ijo.2012.1501", "22664937"]}, {"Citation": "Jiang S.X., Qi B., Yao W.J., Gu C.W., Wei X.F., Zhao Y., Liu Y.Z., Zhao B.S. Berberine displays antitumor activity in esophageal cancer cells in vitro. World J. Gastroenterol. 2017;23:2511\u20132518. doi: 10.3748/wjg.v23.i14.2511.", "ArticleIdList": ["10.3748/wjg.v23.i14.2511", "PMC5394514", "28465635"]}, {"Citation": "Lin C.W., Chin H.K., Lee S.L., Chiu C.F., Chung J.G., Lin Z.Y., Wu C.Y., Liu Y.C., Hsiao Y.T., Feng C.H., et al. Ursolic acid induces apoptosis and autophagy in oral cancer cells. Environ. Toxicol. 2019;34:983\u2013991. doi: 10.1002/tox.22769.", "ArticleIdList": ["10.1002/tox.22769", "31062913"]}, {"Citation": "Qiu Y., Li C., Wang Q., Zeng X., Ji P. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line. Cancer Med. 2018;7:397\u2013407. doi: 10.1002/cam4.1281.", "ArticleIdList": ["10.1002/cam4.1281", "PMC5806115", "29316373"]}, {"Citation": "Chow S.E., Chen Y.W., Liang C.A., Huang Y.K., Wang J.S. Wogonin induces cross-regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cells. J. Cell Biochem. 2012;113:3476\u20133485. doi: 10.1002/jcb.24224.", "ArticleIdList": ["10.1002/jcb.24224", "22689083"]}, {"Citation": "Chien M.H., Yang W.E., Yang Y.C., Ku C.C., Lee W.J., Tsai M.Y., Lin C.W., Yang S.F. Dual Targeting of the p38 MAPK-HO-1 Axis and cIAP1/XIAP by Demethoxycurcumin Triggers Caspase-Mediated Apoptotic Cell Death in Oral Squamous Cell Carcinoma Cells. Cancers. 2020;12:703. doi: 10.3390/cancers12030703.", "ArticleIdList": ["10.3390/cancers12030703", "PMC7140023", "32188144"]}, {"Citation": "Lee E., Han A.R., Nam B., Kim Y.R., Jin C.H., Kim J.B., Eun Y.G., Jung C.H. Moscatilin Induces Apoptosis in Human Head and Neck Squamous Cell Carcinoma Cells via JNK Signaling Pathway. Molecules. 2020;25:901. doi: 10.3390/molecules25040901.", "ArticleIdList": ["10.3390/molecules25040901", "PMC7071095", "32085431"]}, {"Citation": "Porta C., Paglino C., Mosca A. Targeting PI3K/Akt/mTOR Signaling in Cancer. Front. Oncol. 2014;4:64. doi: 10.3389/fonc.2014.00064.", "ArticleIdList": ["10.3389/fonc.2014.00064", "PMC3995050", "24782981"]}, {"Citation": "Yang J., Ren X., Zhang L., Li Y., Cheng B., Xia J. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway. Biomed. Pharmacother. 2018;100:226\u2013232. doi: 10.1016/j.biopha.2018.02.011.", "ArticleIdList": ["10.1016/j.biopha.2018.02.011", "29432993"]}, {"Citation": "Huang C., Yu Y. Synergistic Cytotoxicity of beta-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling Pathway. Med. Sci. Monit. 2017;23:1507\u20131513. doi: 10.12659/MSM.903783.", "ArticleIdList": ["10.12659/MSM.903783", "PMC5383012", "28355175"]}, {"Citation": "Hsu P.C., Cheng C.F., Hsieh P.C., Chen Y.H., Kuo C.Y., Sytwu H.K. Chrysophanol Regulates Cell Death, Metastasis, and Reactive Oxygen Species Production in Oral Cancer Cell Lines. Evid. Based Complement. Alternat. Med. 2020;2020:5867064. doi: 10.1155/2020/5867064.", "ArticleIdList": ["10.1155/2020/5867064", "PMC7271060", "32595733"]}, {"Citation": "Irimie A.I., Braicu C., Zanoaga O., Pileczki V., Gherman C., Berindan-Neagoe I., Campian R.S. Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells. Onco Targets Ther. 2015;8:461\u2013470. doi: 10.2147/OTT.S78358.", "ArticleIdList": ["10.2147/OTT.S78358", "PMC4346003", "25759589"]}, {"Citation": "Shi X., Wang L., Li X., Bai J., Li J., Li S., Wang Z., Zhou M. Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand break-mediated oxidative stress. Oncotarget. 2017;8:45981\u201345993. doi: 10.18632/oncotarget.17520.", "ArticleIdList": ["10.18632/oncotarget.17520", "PMC5542242", "28526807"]}, {"Citation": "Ding L., Wang S., Qu X., Wang J. Tanshinone IIA sensitizes oral sqaumous cell carcinoma to radiation due to an enhanced autophagy. Environ. Toxicol. Pharmacol. 2016;46:264\u2013269. doi: 10.1016/j.etap.2016.07.021.", "ArticleIdList": ["10.1016/j.etap.2016.07.021", "27521571"]}, {"Citation": "Lee H.M., Patel V., Shyur L.F., Lee W.L. Copper supplementation amplifies the anti-tumor effect of curcumin in oral cancer cells. Phytomedicine. 2016;23:1535\u20131544. doi: 10.1016/j.phymed.2016.09.005.", "ArticleIdList": ["10.1016/j.phymed.2016.09.005", "27765374"]}, {"Citation": "Milano F., Mari L., van de Luijtgaarden W., Parikh K., Calpe S., Krishnadath K.K. Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response. Front. Oncol. 2013;3:137. doi: 10.3389/fonc.2013.00137.", "ArticleIdList": ["10.3389/fonc.2013.00137", "PMC3665944", "23755374"]}, {"Citation": "Shin Y.S., Kang S.U., Park J.K., Kim Y.E., Kim Y.S., Baek S.J., Lee S.H., Kim C.H. Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of beta-catenin. Phytomedicine. 2016;23:1344\u20131355. doi: 10.1016/j.phymed.2016.07.005.", "ArticleIdList": ["10.1016/j.phymed.2016.07.005", "27765354"]}, {"Citation": "Lin R., Zhang Z., Chen L., Zhou Y., Zou P., Feng C., Wang L., Liang G. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells. Cancer Lett. 2016;381:165\u2013175. doi: 10.1016/j.canlet.2016.07.033.", "ArticleIdList": ["10.1016/j.canlet.2016.07.033", "27477901"]}, {"Citation": "Li Y., Sui H., Jiang C., Li S., Han Y., Huang P., Du X., Du J., Bai Y. Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-kappaB/HIF-1alpha/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo. Cell Physiol. Biochem. 2018;48:2035\u20132045. doi: 10.1159/000492541.", "ArticleIdList": ["10.1159/000492541", "30099443"]}, {"Citation": "Zhang W., Kang M., Zhang T., Li B., Liao X., Wang R. Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-kappaB-Related Mechanism. Int. J. Mol. Sci. 2016;17:2139. doi: 10.3390/ijms17122139.", "ArticleIdList": ["10.3390/ijms17122139", "PMC5187939", "27999372"]}, {"Citation": "Liu T., Sun X., Cao Z. Shikonin-induced necroptosis in nasopharyngeal carcinoma cells via ROS overproduction and upregulation of RIPK1/RIPK3/MLKL expression. Onco Targets Ther. 2019;12:2605\u20132614. doi: 10.2147/OTT.S200740.", "ArticleIdList": ["10.2147/OTT.S200740", "PMC6498394", "31118661"]}, {"Citation": "Liu G., Wu D., Liang X., Yue H., Cui Y. Mechanisms and in vitro effects of cepharanthine hydrochloride: Classification analysis of the drug-induced differentially-expressed genes of human nasopharyngeal carcinoma cells. Oncol. Rep. 2015;34:2002\u20132010. doi: 10.3892/or.2015.4193.", "ArticleIdList": ["10.3892/or.2015.4193", "26260412"]}, {"Citation": "Chien M.H., Lin C.W., Cheng C.W., Wen Y.C., Yang S.F. Matrix metalloproteinase-2 as a target for head and neck cancer therapy. Expert Opin. Ther. Targets. 2013;17:203\u2013216. doi: 10.1517/14728222.2013.740012.", "ArticleIdList": ["10.1517/14728222.2013.740012", "23252422"]}, {"Citation": "Bachmeier B.E., Iancu C.M., Jochum M., Nerlich A.G. Matrix metalloproteinases in cancer: Comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev. Anticancer Ther. 2005;5:149\u2013163. doi: 10.1586/14737140.5.1.149.", "ArticleIdList": ["10.1586/14737140.5.1.149", "15757447"]}, {"Citation": "Li L., Yue G.G., Lee J.K., Wong E.C., Fung K.P., Yu J., Lau C.B., Chiu P.W. Gene expression profiling reveals the plausible mechanisms underlying the antitumor and antimetastasis effects of Andrographis paniculata in esophageal cancer. Phytother. Res. 2018;32:1388\u20131396. doi: 10.1002/ptr.6074.", "ArticleIdList": ["10.1002/ptr.6074", "29577460"]}, {"Citation": "Li L., Yue G.G., Lee J.K., Wong E.C., Fung K.P., Yu J., Lau C.B., Chiu P.W. The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment\u2014From preclinical perspectives. Sci. Rep. 2017;7:854. doi: 10.1038/s41598-017-00934-x.", "ArticleIdList": ["10.1038/s41598-017-00934-x", "PMC5429803", "28405006"]}, {"Citation": "Yue G.G., Lee J.K., Li L., Chan K.M., Wong E.C., Chan J.Y., Fung K.P., Lui V.W., Chiu P.W., Lau C.B. Andrographis paniculata elicits anti-invasion activities by suppressing TM4SF3 gene expression and by anoikis-sensitization in esophageal cancer cells. Am. J. Cancer Res. 2015;5:3570\u20133587.", "ArticleIdList": ["PMC4731632", "26885447"]}, {"Citation": "Liao M.Y., Chuang C.Y., Hsieh M.J., Chou Y.E., Lin C.W., Chen W.R., Lai C.T., Chen M.K., Yang S.F. Antimetastatic effects of Eclipta prostrata extract on oral cancer cells. Environ. Toxicol. 2018;33:923\u2013930. doi: 10.1002/tox.22577.", "ArticleIdList": ["10.1002/tox.22577", "29962088"]}, {"Citation": "Hsin C.H., Huang C.C., Chen P.N., Hsieh Y.S., Yang S.F., Ho Y.T., Lin C.W. Rubus idaeus Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Suppression of MMP-2 through Modulation of the ERK1/2 Pathway. Am. J. Chin. Med. 2017;45:1557\u20131572. doi: 10.1142/S0192415X17500847.", "ArticleIdList": ["10.1142/S0192415X17500847", "28946771"]}, {"Citation": "Huang Y.W., Chuang C.Y., Hsieh Y.S., Chen P.N., Yang S.F., Shih Hsuan L., Chen Y.Y., Lin C.W., Chang Y.C. Rubus idaeus extract suppresses migration and invasion of human oral cancer by inhibiting MMP-2 through modulation of the Erk1/2 signaling pathway. Environ. Toxicol. 2017;32:1037\u20131046. doi: 10.1002/tox.22302.", "ArticleIdList": ["10.1002/tox.22302", "27322511"]}, {"Citation": "Yang J.S., Lin C.W., Hsieh Y.S., Cheng H.L., Lue K.H., Yang S.F., Lu K.H. Selaginella tamariscina (Beauv.) possesses antimetastatic effects on human osteosarcoma cells by decreasing MMP-2 and MMP-9 secretions via p38 and Akt signaling pathways. Food Chem. Toxicol. 2013;59:801\u2013807. doi: 10.1016/j.fct.2013.06.028.", "ArticleIdList": ["10.1016/j.fct.2013.06.028", "23811101"]}, {"Citation": "Yang W.E., Ho Y.C., Tang C.M., Hsieh Y.S., Chen P.N., Lai C.T., Yang S.F., Lin C.W. Duchesnea indica extract attenuates oral cancer cells metastatic potential through the inhibition of the matrix metalloproteinase-2 activity by down-regulating the MEK/ERK pathway. Phytomedicine. 2019;63:152960. doi: 10.1016/j.phymed.2019.152960.", "ArticleIdList": ["10.1016/j.phymed.2019.152960", "31280137"]}, {"Citation": "Chung H.H., Chen M.K., Chang Y.C., Yang S.F., Lin C.C., Lin C.W. Inhibitory effects of Leucaena leucocephala on the metastasis and invasion of human oral cancer cells. Environ. Toxicol. 2017;32:1765\u20131774. doi: 10.1002/tox.22399.", "ArticleIdList": ["10.1002/tox.22399", "28181379"]}, {"Citation": "Hseu Y.C., Wu C.R., Chang H.W., Kumar K.J., Lin M.K., Chen C.S., Cho H.J., Huang C.Y., Huang C.Y., Lee H.Z., et al. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis. J. Ethnopharmacol. 2011;135:762\u2013771. doi: 10.1016/j.jep.2011.04.016.", "ArticleIdList": ["10.1016/j.jep.2011.04.016", "21515352"]}, {"Citation": "Schmidt M., Scholz C.J., Gavril G.L., Otto C., Polednik C., Roller J., Hagen R. Effect of Galium verum aqueous extract on growth, motility and gene expression in drug-sensitive and -resistant laryngeal carcinoma cell lines. Int. J. Oncol. 2014;44:745\u2013760. doi: 10.3892/ijo.2013.2220.", "ArticleIdList": ["10.3892/ijo.2013.2220", "24366449"]}, {"Citation": "Chen Y.Y., Hsieh M.J., Hsieh Y.S., Chang Y.C., Chen P.N., Yang S.F., Ho H.Y., Chou Y.E., Lin C.W. Antimetastatic effects of Rheum palmatum L. extract on oral cancer cells. Environ. Toxicol. 2017;32:2287\u20132294. doi: 10.1002/tox.22444.", "ArticleIdList": ["10.1002/tox.22444", "28678381"]}, {"Citation": "Chen Y.Y., Chiang S.Y., Lin J.G., Ma Y.S., Liao C.L., Weng S.W., Lai T.Y., Chung J.G. Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. Int. J. Oncol. 2010;36:1113\u20131120. doi: 10.3892/ijo_00000593.", "ArticleIdList": ["10.3892/ijo_00000593", "20372784"]}, {"Citation": "Ho Y.T., Yang J.S., Li T.C., Lin J.J., Lin J.G., Lai K.C., Ma C.Y., Wood W.G., Chung J.G. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Lett. 2009;279:155\u2013162. doi: 10.1016/j.canlet.2009.01.033.", "ArticleIdList": ["10.1016/j.canlet.2009.01.033", "19251361"]}, {"Citation": "Lu K.W., Chen J.C., Lai T.Y., Yang J.S., Weng S.W., Ma Y.S., Lu P.J., Weng J.R., Chueh F.S., Wood W.G., et al. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways. Hum. Exp. Toxicol. 2011;30:406\u2013415. doi: 10.1177/0960327110372405.", "ArticleIdList": ["10.1177/0960327110372405", "20511288"]}, {"Citation": "Chung T.T., Chuang C.Y., Teng Y.H., Hsieh M.J., Lai J.C., Chuang Y.T., Chen M.K., Yang S.F. Tricetin suppresses human oral cancer cell migration by reducing matrix metalloproteinase-9 expression through the mitogen-activated protein kinase signaling pathway. Environ. Toxicol. 2017;32:2392\u20132399. doi: 10.1002/tox.22452.", "ArticleIdList": ["10.1002/tox.22452", "28731287"]}, {"Citation": "Chen M.K., Liu Y.T., Lin J.T., Lin C.C., Chuang Y.C., Lo Y.S., Hsi Y.T., Hsieh M.J. Pinosylvin reduced migration and invasion of oral cancer carcinoma by regulating matrix metalloproteinase-2 expression and extracellular signal-regulated kinase pathway. Biomed. Pharmacother. 2019;117:109160. doi: 10.1016/j.biopha.2019.109160.", "ArticleIdList": ["10.1016/j.biopha.2019.109160", "31387166"]}, {"Citation": "Fang C.Y., Wu C.Z., Chen P.N., Chang Y.C., Chuang C.Y., Lai C.T., Yang S.F., Tsai L.L. Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway. Environ. Toxicol. 2018;33:545\u2013554. doi: 10.1002/tox.22542.", "ArticleIdList": ["10.1002/tox.22542", "29385302"]}, {"Citation": "Lai W.W., Hsu S.C., Chueh F.S., Chen Y.Y., Yang J.S., Lin J.P., Lien J.C., Tsai C.H., Chung J.G. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-kappaB and matrix metalloproteinase-2/-9 signaling pathways. Anticancer Res. 2013;33:1941\u20131950.", "ArticleIdList": ["23645742"]}, {"Citation": "Chen H.J., Lin C.M., Lee C.Y., Shih N.C., Amagaya S., Lin Y.C., Yang J.S. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling. Int. J. Oncol. 2013;43:629\u2013637. doi: 10.3892/ijo.2013.1977.", "ArticleIdList": ["10.3892/ijo.2013.1977", "23754208"]}, {"Citation": "Pang J.S., Yen J.H., Wu H.T., Huang S.T. Gallic Acid Inhibited Matrix Invasion and AP-1/ETS-1-Mediated MMP-1 Transcription in Human Nasopharyngeal Carcinoma Cells. Int. J. Mol. Sci. 2017;18:1354. doi: 10.3390/ijms18071354.", "ArticleIdList": ["10.3390/ijms18071354", "PMC5535847", "28672814"]}, {"Citation": "Peng X., Zhang Q., Zeng Y., Li J., Wang L., Ai P. Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression. Cancer Chemother. Pharmacol. 2015;76:1173\u20131184. doi: 10.1007/s00280-015-2902-9.", "ArticleIdList": ["10.1007/s00280-015-2902-9", "26546460"]}, {"Citation": "Chien S.Y., Hsieh M.J., Chen C.J., Yang S.F., Chen M.K. Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2. Expert Opin. Ther. Targets. 2015;19:307\u2013320. doi: 10.1517/14728222.2014.992875.", "ArticleIdList": ["10.1517/14728222.2014.992875", "25563790"]}, {"Citation": "Lin F.Y., Hsieh Y.H., Yang S.F., Chen C.T., Tang C.H., Chou M.Y., Chuang Y.T., Lin C.W., Chen M.K. Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells. J. Oral. Pathol. Med. 2015;44:699\u2013706. doi: 10.1111/jop.12288.", "ArticleIdList": ["10.1111/jop.12288", "25401496"]}, {"Citation": "Li S., Jiang S., Jiang W., Zhou Y., Shen X.Y., Luo T., Kong L.P., Wang H.Q. Anticancer effects of crocetin in human esophageal squamous cell carcinoma KYSE-150 cells. Oncol. Lett. 2015;9:1254\u20131260. doi: 10.3892/ol.2015.2869.", "ArticleIdList": ["10.3892/ol.2015.2869", "PMC4315057", "25663893"]}, {"Citation": "Hsieh M.J., Chin M.C., Lin C.C., His Y.T., Lo Y.S., Chuang Y.C., Chen M.K. Pinostilbene Hydrate Suppresses Human Oral Cancer Cell Metastasis by Downregulation of Matrix Metalloproteinase-2 Through the Mitogen-Activated Protein Kinase Signaling Pathway. Cell Physiol. Biochem. 2018;50:911\u2013923. doi: 10.1159/000494476.", "ArticleIdList": ["10.1159/000494476", "30355929"]}, {"Citation": "Lin C.H., Shen Y.A., Hung P.H., Yu Y.B., Chen Y.J. Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines. BMC Complement. Altern. Med. 2012;12:201. doi: 10.1186/1472-6882-12-201.", "ArticleIdList": ["10.1186/1472-6882-12-201", "PMC3575296", "23110507"]}, {"Citation": "Fang C.Y., Wu C.C., Hsu H.Y., Chuang H.Y., Huang S.Y., Tsai C.H., Chang Y., Tsao G.S., Chen C.L., Chen J.Y. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells. Int. J. Mol. Sci. 2015;16:2530\u20132558. doi: 10.3390/ijms16022530.", "ArticleIdList": ["10.3390/ijms16022530", "PMC4346850", "25625511"]}, {"Citation": "Li Y.J., Wu S.L., Lu S.M., Chen F., Guo Y., Gan S.M., Shi Y.L., Liu S., Li S.L. (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-kappaB p65 inactivation. Tumour. Biol. 2015;36:2747\u20132761. doi: 10.1007/s13277-014-2899-4.", "ArticleIdList": ["10.1007/s13277-014-2899-4", "25487615"]}, {"Citation": "Chang C.M., Chang P.Y., Tu M.G., Lu C.C., Kuo S.C., Amagaya S., Lee C.Y., Jao H.Y., Chen M.Y., Yang J.S. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2. Oncol. Rep. 2012;28:1799\u20131807. doi: 10.3892/or.2012.1991.", "ArticleIdList": ["10.3892/or.2012.1991", "22923287"]}, {"Citation": "Shi H., Shi D., Wu Y., Shen Q., Li J. Qigesan inhibits migration and invasion of esophageal cancer cells via inducing connexin expression and enhancing gap junction function. Cancer Lett. 2016;380:184\u2013190. doi: 10.1016/j.canlet.2016.06.015.", "ArticleIdList": ["10.1016/j.canlet.2016.06.015", "27345741"]}, {"Citation": "Zhao J.X., Li X.F., Wang X.X. Effects of body-resistance strengthening and tumor-suppressing granules on immune adhesion function of red blood cells and expression of metastasis protein CD44 in tumor cells of patients with esophageal carcinoma. World J. Gastroenterol. 2007;13:4360\u20134364. doi: 10.3748/wjg.v13.i32.4360.", "ArticleIdList": ["10.3748/wjg.v13.i32.4360", "PMC4250865", "17708612"]}, {"Citation": "Shi Q., Diao Y., Jin F., Ding Z. Antimetastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelialmesenchymal transition and angiogenesis. Mol. Med. Rep. 2018;18:131\u2013138. doi: 10.3892/mmr.2018.8976.", "ArticleIdList": ["10.3892/mmr.2018.8976", "PMC6059661", "29749455"]}, {"Citation": "Chaudhary A.K., Singh M., Bharti A.C., Asotra K., Sundaram S., Mehrotra R. Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J. Biomed. Sci. 2010;17:10. doi: 10.1186/1423-0127-17-10.", "ArticleIdList": ["10.1186/1423-0127-17-10", "PMC2846899", "20152059"]}, {"Citation": "Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell. Biol. 2002;4:E131\u2013E136. doi: 10.1038/ncb0502-e131.", "ArticleIdList": ["10.1038/ncb0502-e131", "11988758"]}, {"Citation": "Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37\u201340. doi: 10.1038/35065000.", "ArticleIdList": ["10.1038/35065000", "11242034"]}, {"Citation": "Alizadeh A.M., Shiri S., Farsinejad S. Metastasis review: From bench to bedside. Tumour. Biol. 2014;35:8483\u20138523. doi: 10.1007/s13277-014-2421-z.", "ArticleIdList": ["10.1007/s13277-014-2421-z", "25104089"]}, {"Citation": "Guan X. Cancer metastases: Challenges and opportunities. Acta Pharm. Sin. B. 2015;5:402\u2013418. doi: 10.1016/j.apsb.2015.07.005.", "ArticleIdList": ["10.1016/j.apsb.2015.07.005", "PMC4629446", "26579471"]}, {"Citation": "Paoli P., Giannoni E., Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim. Biophys. Acta. 2013;1833:3481\u20133498. doi: 10.1016/j.bbamcr.2013.06.026.", "ArticleIdList": ["10.1016/j.bbamcr.2013.06.026", "23830918"]}, {"Citation": "Apte R.S., Chen D.S., Ferrara N. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019;176:1248\u20131264. doi: 10.1016/j.cell.2019.01.021.", "ArticleIdList": ["10.1016/j.cell.2019.01.021", "PMC6410740", "30849371"]}, {"Citation": "Folgueras A.R., Pendas A.M., Sanchez L.M., Lopez-Otin C. Matrix metalloproteinases in cancer: From new functions to improved inhibition strategies. Int. J. Dev. Biol. 2004;48:411\u2013424. doi: 10.1387/ijdb.041811af.", "ArticleIdList": ["10.1387/ijdb.041811af", "15349816"]}, {"Citation": "Santuray R.T., Johnson D.E., Grandis J.R. New Therapies in Head and Neck Cancer. Trends Cancer. 2018;4:385\u2013396. doi: 10.1016/j.trecan.2018.03.006.", "ArticleIdList": ["10.1016/j.trecan.2018.03.006", "PMC6226306", "29709262"]}, {"Citation": "Cognetti D.M., Weber R.S., Lai S.Y. Head and neck cancer: An evolving treatment paradigm. Cancer. 2008;113:1911\u20131932. doi: 10.1002/cncr.23654.", "ArticleIdList": ["10.1002/cncr.23654", "PMC2751600", "18798532"]}, {"Citation": "Du E., Mazul A.L., Farquhar D., Brennan P., Anantharaman D., Abedi-Ardekani B., Weissler M.C., Hayes D.N., Olshan A.F., Zevallos J.P. Long-term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status. Laryngoscope. 2019;129:2506\u20132513. doi: 10.1002/lary.27807.", "ArticleIdList": ["10.1002/lary.27807", "PMC6907689", "30637762"]}, {"Citation": "Yu C.H., Lin H.P., Cheng S.J., Sun A., Chen H.M. Cryotherapy for oral precancers and cancers. J. Formos. Med. Assoc. 2014;113:272\u2013277. doi: 10.1016/j.jfma.2014.01.014.", "ArticleIdList": ["10.1016/j.jfma.2014.01.014", "24560447"]}, {"Citation": "Biel M.A. Photodynamic therapy of head and neck cancers. Methods Mol. Biol. 2010;635:281\u2013293. doi: 10.1007/978-1-60761-697-9_18.", "ArticleIdList": ["10.1007/978-1-60761-697-9_18", "20552353"]}, {"Citation": "Mimikos C., Shafirstein G., Arshad H. Current state and future of photodynamic therapy for the treatment of head and neck squamous cell carcinoma. World J. Otorhinolaryngol. Head Neck Surg. 2016;2:126\u2013129. doi: 10.1016/j.wjorl.2016.05.011.", "ArticleIdList": ["10.1016/j.wjorl.2016.05.011", "PMC5376070", "28374020"]}, {"Citation": "Kozakiewicz P., Grzybowska-Szatkowska L. Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma. Oncol. Lett. 2018;15:7497\u20137505. doi: 10.3892/ol.2018.8300.", "ArticleIdList": ["10.3892/ol.2018.8300", "PMC5920345", "29725456"]}, {"Citation": "Ansell A., Jedlinski A., Johansson A.C., Roberg K. Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells. J. Oral. Pathol. Med. 2016;45:9\u201316. doi: 10.1111/jop.12310.", "ArticleIdList": ["10.1111/jop.12310", "25677871"]}, {"Citation": "Cognetti F., Pinnaro P., Carlini P., Ruggeri E.M., Ambesi Impiombato F., Del Vecchio M.R., Giannarelli D., Perrino A. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer. Cancer. 1988;62:251\u2013261. doi: 10.1002/1097-0142(19880715)62:2<251::AID-CNCR2820620205>3.0.CO;2-J.", "ArticleIdList": ["10.1002/1097-0142(19880715)62:2<251::AID-CNCR2820620205>3.0.CO;2-J", "2454721"]}, {"Citation": "Higuchi E., Oridate N., Furuta Y., Suzuki S., Hatakeyama H., Sawa H., Sunayashiki-Kusuzaki K., Yamazaki K., Inuyama Y., Fukuda S. Differentially expressed genes associated with CIS-diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and CDNA microarray. Head Neck. 2003;25:187\u2013193. doi: 10.1002/hed.10204.", "ArticleIdList": ["10.1002/hed.10204", "12599285"]}, {"Citation": "Suzuki M., Ishikawa H., Tanaka A., Mataga I. Heterogeneity of anticancer drug sensitivity in squamous cell carcinoma of the tongue. Hum. Cell. 2011;24:21\u201329. doi: 10.1007/s13577-010-0004-x.", "ArticleIdList": ["10.1007/s13577-010-0004-x", "21547692"]}, {"Citation": "Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer. 2002;2:48\u201358. doi: 10.1038/nrc706.", "ArticleIdList": ["10.1038/nrc706", "11902585"]}, {"Citation": "Lopez-Verdin S., Lavalle-Carrasco J., Carreon-Burciaga R.G., Serafin-Higuera N., Molina-Frechero N., Gonzalez-Gonzalez R., Bologna-Molina R. Molecular Markers of Anticancer Drug Resistance in Head and Neck Squamous Cell Carcinoma: A Literature Review. Cancers. 2018;10:376. doi: 10.3390/cancers10100376.", "ArticleIdList": ["10.3390/cancers10100376", "PMC6210289", "30308958"]}, {"Citation": "Zhang J., Zhou F., Wu X., Zhang X., Chen Y., Zha B.S., Niu F., Lu M., Hao G., Sun Y., et al. Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells. Br. J. Pharmacol. 2012;165:120\u2013134. doi: 10.1111/j.1476-5381.2011.01505.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01505.x", "PMC3252972", "21615726"]}, {"Citation": "Jiang Z., Yang Y., Yang Y., Zhang Y., Yue Z., Pan Z., Ren X. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune. Biomed. Pharmacother. 2017;96:378\u2013383. doi: 10.1016/j.biopha.2017.09.129.", "ArticleIdList": ["10.1016/j.biopha.2017.09.129", "29031195"]}, {"Citation": "Li X., Wang H., Wang J., Chen Y., Yin X., Shi G., Li H., Hu Z., Liang X. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation. BMC Cancer. 2016;16:578. doi: 10.1186/s12885-016-2640-3.", "ArticleIdList": ["10.1186/s12885-016-2640-3", "PMC4971704", "27485374"]}, {"Citation": "Wang J., Yuan Z. Gambogic acid sensitizes ovarian cancer cells to doxorubicin through ROS-mediated apoptosis. Cell Biochem. Biophys. 2013;67:199\u2013206. doi: 10.1007/s12013-013-9534-7.", "ArticleIdList": ["10.1007/s12013-013-9534-7", "23436279"]}, {"Citation": "Lin H.L., Liu T.Y., Wu C.W., Chi C.W. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel. Br. J. Cancer. 1999;81:416\u2013422. doi: 10.1038/sj.bjc.6690710.", "ArticleIdList": ["10.1038/sj.bjc.6690710", "PMC2362909", "10507765"]}, {"Citation": "Roh J.L., Kim E.H., Jang H., Shin D. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox. Biol. 2017;11:254\u2013262. doi: 10.1016/j.redox.2016.12.010.", "ArticleIdList": ["10.1016/j.redox.2016.12.010", "PMC5198738", "28012440"]}, {"Citation": "Kim E.H., Jang H., Shin D., Baek S.H., Roh J.L. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer. Apoptosis. 2016;21:1265\u20131278. doi: 10.1007/s10495-016-1284-8.", "ArticleIdList": ["10.1007/s10495-016-1284-8", "27544755"]}, {"Citation": "Bauer J.A., Trask D.K., Kumar B., Los G., Castro J., Lee J.S., Chen J., Wang S., Bradford C.R., Carey T.E. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: Role of wild-type p53 and Bcl-xL. Mol. Cancer. Ther. 2005;4:1096\u20131104. doi: 10.1158/1535-7163.MCT-05-0081.", "ArticleIdList": ["10.1158/1535-7163.MCT-05-0081", "16020667"]}, {"Citation": "Oliver C.L., Bauer J.A., Wolter K.G., Ubell M.L., Narayan A., O\u2019Connell K.M., Fisher S.G., Wang S., Wu X., Ji M., et al. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells. Clin. Cancer Res. 2004;10:7757\u20137763. doi: 10.1158/1078-0432.CCR-04-0551.", "ArticleIdList": ["10.1158/1078-0432.CCR-04-0551", "15570010"]}, {"Citation": "Rasheed Z.A., Kowalski J., Smith B.D., Matsui W. Concise review: Emerging concepts in clinical targeting of cancer stem cells. Stem. Cells. 2011;29:883\u2013887. doi: 10.1002/stem.648.", "ArticleIdList": ["10.1002/stem.648", "PMC3355871", "21509907"]}, {"Citation": "Frank N.Y., Schatton T., Frank M.H. The therapeutic promise of the cancer stem cell concept. J. Clin. Investig. 2010;120:41\u201350. doi: 10.1172/JCI41004.", "ArticleIdList": ["10.1172/JCI41004", "PMC2798700", "20051635"]}, {"Citation": "Moore N., Lyle S. Quiescent, slow-cycling stem cell populations in cancer: A review of the evidence and discussion of significance. J. Oncol. 2011;2011 doi: 10.1155/2011/396076.", "ArticleIdList": ["10.1155/2011/396076", "PMC2948913", "20936110"]}, {"Citation": "Lee S.H., Nam H.J., Kang H.J., Kwon H.W., Lim Y.C. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway. Eur. J. Cancer. 2013;49:3210\u20133218. doi: 10.1016/j.ejca.2013.06.025.", "ArticleIdList": ["10.1016/j.ejca.2013.06.025", "23876835"]}, {"Citation": "Yang C.Y., Hsieh C.C., Lin C.K., Lin C.S., Peng B., Lin G.J., Sytwu H.K., Chang W.L., Chen Y.W. Danshen extract circumvents drug resistance and represses cell growth in human oral cancer cells. BMC Complement. Altern. Med. 2017;17:555. doi: 10.1186/s12906-017-2063-y.", "ArticleIdList": ["10.1186/s12906-017-2063-y", "PMC5747158", "29284481"]}, {"Citation": "Lin F.Z., Wang S.C., Hsi Y.T., Lo Y.S., Lin C.C., Chuang Y.C., Lin S.H., Hsieh M.J., Chen M.K. Celastrol induces vincristine multidrug resistance oral cancer cell apoptosis by targeting JNK1/2 signaling pathway. Phytomedicine. 2019;54:1\u20138. doi: 10.1016/j.phymed.2018.09.181.", "ArticleIdList": ["10.1016/j.phymed.2018.09.181", "30668359"]}, {"Citation": "Pinna R., Campus G., Cumbo E., Mura I., Milia E. Xerostomia induced by radiotherapy: An overview of the physiopathology, clinical evidence, and management of the oral damage. Ther. Clin. Risk Manag. 2015;11:171\u2013188. doi: 10.2147/TCRM.S70652.", "ArticleIdList": ["10.2147/TCRM.S70652", "PMC4325830", "25691810"]}, {"Citation": "Vera-Llonch M., Oster G., Hagiwara M., Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006;106:329\u2013336. doi: 10.1002/cncr.21622.", "ArticleIdList": ["10.1002/cncr.21622", "16342066"]}, {"Citation": "Rogers S.N., Ahad S.A., Murphy A.P. A structured review and theme analysis of papers published on \u2018quality of life\u2019 in head and neck cancer: 2000-2005. Oral. Oncol. 2007;43:843\u2013868. doi: 10.1016/j.oraloncology.2007.02.006.", "ArticleIdList": ["10.1016/j.oraloncology.2007.02.006", "17600755"]}, {"Citation": "Jensen S.B., Pedersen A.M., Vissink A., Andersen E., Brown C.G., Davies A.N., Dutilh J., Fulton J.S., Jankovic L., Lopes N.N., et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: Management strategies and economic impact. Support. Care Cancer. 2010;18:1061\u20131079. doi: 10.1007/s00520-010-0837-6.", "ArticleIdList": ["10.1007/s00520-010-0837-6", "20333412"]}, {"Citation": "Vissink A., Mitchell J.B., Baum B.J., Limesand K.H., Jensen S.B., Fox P.C., Elting L.S., Langendijk J.A., Coppes R.P., Reyland M.E. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Successes and barriers. Int. J. Radiat. Oncol. Biol. Phys. 2010;78:983\u2013991. doi: 10.1016/j.ijrobp.2010.06.052.", "ArticleIdList": ["10.1016/j.ijrobp.2010.06.052", "PMC2964345", "20970030"]}, {"Citation": "Plemons J.M., Al-Hashimi I., Marek C.L. Americal Dental Association Council on Scientific Affairs. Managing xerostomia and salivary gland hypofunction: Executive summary of a report from the American Dental Association Council on Scirntific Affairs. J. Am. Dent. Assoc. 2014;145:867\u2013873. doi: 10.14219/jada.2014.44.", "ArticleIdList": ["10.14219/jada.2014.44", "25082939"]}, {"Citation": "Yarom N., Hovan A., Bossi P., Ariyawardana A., Jensen S.B., Gobbo M., Saca-Hazboun H., Kandwal A., Majorana A., Ottaviani G., et al. Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guideline\u2014Part 2: Honey, herbal compounds, saliva stumulants, probiotics, and miscellaneous agents. Support. Care Cancer. 2020;28:2457\u20132472. doi: 10.1007/s00520-019-05256-4.", "ArticleIdList": ["10.1007/s00520-019-05256-4", "32056010"]}, {"Citation": "Ameri A., Heydarirad G., Rezaeizadeh H., Choopani R., Ghobadi A., Gachkar L. Evaluation of Efficacy of an Herbal Compound on Dry Mouth in Patients With Head and Neck Cancers: A Randomized Clinical Trial. J. Evid. Based Complementary Altern. Med. 2016;21:30\u201333. doi: 10.1177/2156587215590232.", "ArticleIdList": ["10.1177/2156587215590232", "26137850"]}, {"Citation": "Nik Nabil W.N., Lim R.J., Chan S.Y., Lai N.M., Liew A.C. A systematic review on Chinese herbal treatment for radiotherapy-induced xerostomia in head and neck cancer patients. Complement. Ther. Clin. Pract. 2018;30:6\u201313. doi: 10.1016/j.ctcp.2017.10.004.", "ArticleIdList": ["10.1016/j.ctcp.2017.10.004", "29389481"]}, {"Citation": "Wang G., Jia L. Herb medicine for relieving radiation induced oral mucositis: A systematic review and meta-analysis protocol. Medicine (Baltimore) 2019;98:e18337. doi: 10.1097/MD.0000000000018337.", "ArticleIdList": ["10.1097/MD.0000000000018337", "PMC6922437", "31852129"]}, {"Citation": "Bensinger W., Schubert M., Ang K.K., Brizel D., Brown E., Eilers J.G., Elting L., Mittal B.B., Schattner M.A., Spielberger R., et al. NCCN Task Force Report. prevention and management of mucositis in cancer care. J. Natl. Compr. Cancer Netw. 2008;6(Suppl. S1):1\u201321; quiz S22\u2013S24. doi: 10.6004/jnccn.2008.2001.", "ArticleIdList": ["10.6004/jnccn.2008.2001", "18289497"]}, {"Citation": "Soltani G.M., Hemati S., Sarvizadeh M., Kamalinejad M., Tafazoli V., Latifi S.A. Efficacy of the plantago major L. syrup on radiation induced oral mucositis in head and neck cancer patients: A randomized, double blind, placebo-controlled clinical trial. Complement. Ther. Med. 2020;51:102397. doi: 10.1016/j.ctim.2020.102397.", "ArticleIdList": ["10.1016/j.ctim.2020.102397", "32507421"]}, {"Citation": "Baharvand M., Jafari S., Mortazavi H. Herbs in Oral Mucositis. J. Clin. Diagn. Res. 2017;11:ZE05\u2013ZE11. doi: 10.7860/JCDR/2017/21703.9467.", "ArticleIdList": ["10.7860/JCDR/2017/21703.9467", "PMC5427456", "28511530"]}, {"Citation": "Nagi R., Patil D.J., Rakesh N., Jain S., Sahu S. Natural agents in the management of oral mucositis in cancer patients-systematic review. J. Oral. Biol. Craniofac. Res. 2018;8:245\u2013254. doi: 10.1016/j.jobcr.2017.12.003.", "ArticleIdList": ["10.1016/j.jobcr.2017.12.003", "PMC6107930", "30191118"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "30"}, {"Year": "2020", "Month": "9", "Day": "13"}, {"Year": "2020", "Month": "9", "Day": "14"}, {"Year": "2020", "Month": "9", "Day": "18", "Hour": "1", "Minute": "2"}, {"Year": "2020", "Month": "9", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32942674", "PMC7565208", "10.3390/biom10091321", "biom10091321"]}}], "PubmedBookArticle": []}